SKB445 for Injection in Solid Tumors

Clinical trial NCT06826040 · RECRUITING

Trial details

NCT number: NCT06826040
Sponsor: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Solid Tumors

Start date: 2025-02-05
Primary completion: 2026-12-31
Enrollment: 126

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.